Location of Repository

Ampicillin/Sulbactam Vs. Cefoxitin for the Treatment of Pelvic Inflammatory Disease

By Joseph G. Jemsek and Frank Harrison

Abstract

Objective: The safety and efficacy of ampicillin plus sulbactam were compared with those of cefoxitin in the treatment of women with pelvic inflammatory disease (PID)

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:2364580
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1986). A comparison of parenteral sulbactam/ ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease. Drugs 31(Suppl 2):14-17,
    2. Antibiotic regimens for treating acute pelvic inflammatory disease.
    3. (1991). Brunham RC: Treatment of acute pelvic inflammatory disease in the ambulatory setting: Trial of cefoxitin and
    4. (1990). Cates W Jr: Pelvic inflammatory disease. Med Clin North Am 74:1603-1615,
    5. (1982). Disease Control: Sexually transmitted diseases treatment guidelines 1982. MMWR 31(Suppl 2): 33S-60S,
    6. (1992). HF: Amoxycillin/clavulanic acid (augmentin) compared with triple drug therapy for pelvic inflammatory disease.
    7. (1993). Inpatient treatment for uncomplicated and complicated acute pelvic inflammatory disease: Ampicillin/sulbactam vs. cefoxitin. Infect Dis Obstet Gynecol 1:123-129,
    8. (1981). KK: Eradication of Ch/amydia trachomatis from the urethra ofmen with nongonococcal urethritis by treatment with amoxicillin (abstract). Sex Transm Dis 8:79-81,
    9. Nahata MC: Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination (abstract).
    10. (1995). Nakasato S: Conversion of treatment from cefoxitin to ampicillin/sulbactam: Experience in a university teaching hospital.
    11. (1988). O’Keefe JP: Microbiologic considerations in the treatment of serious pelvic infections in women.
    12. (1990). Optimum therapy for acute pelvic inflammatory disease.
    13. Pelvic inflammatory disease: Its pathogenesis, diagnosis, and treatment.
    14. (1994). Pelvic inflammatory disease. Infect Dis Clin North Am 8:821-840,
    15. (1994). RB: Multicenter evaluation of the in vitro activity of piperacillintazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria.
    16. RL: Amoxicillin therapy for Chlamydia trachomatis in pregnancy.
    17. RL: Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
    18. (1992). RL: Longterm sequelae of acute pelvic inflammatory disease: A retrospective cohort study.
    19. (1993). RL: Pelvic inflammatory disease: Mcta-analysis of antimicrobial regimen efficacy.
    20. (1994). RS: Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. Obstet Gynecol 83:998-1004,
    21. (1988). Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
    22. (1986). Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. Drugs 31(Suppl 2):11-13,
    23. (1979). Zaidi AA: Pelvic inflammatory disease: Trends in hospitalizations and office visits,
    24. (1990). Zenilman JM: Pelvic inflammatory disease: Review of treatment options. Rev Infect Dis 12(Suppl 6):$656-$664,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.